AU Stock MarketDetailed Quotes

PAR Paradigm Biopharmaceuticals Ltd

Watchlist
  • 0.520
  • +0.005+0.97%
20min DelayTrading Feb 17 11:23 AET
202.50MMarket Cap-2.60P/E (Static)

Paradigm Biopharmaceuticals Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Paradigm Biopharmaceuticals Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: AUD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 0.000--
--2025/FY-- / 3.000M--
--2024/FY65.800K / 0.000--
--2023/FY46.760K / 5.000K--
--2022/FY79.220K / ----
DatePeriodRevenue/EstimateEarnings Call
--2026/FY-- / 0.000--
--2025/FY-- / 3.000M--
--2024/FY65.800K / 0.000--
--2023/FY46.760K / 5.000K--
--2022/FY79.220K / ----

Unlock Free Earnings Estimates

Paradigm Biopharmaceuticals Ltd Earnings Reports

  • Paradigm Biopharmaceuticals Ltd: Paradigm Receives $6.3m R&D Tax Refund

    Jan 23 16:59 ET

  • Paradigm Biopharmaceuticals Ltd: Appendix 4E and 2024 Annual Report

    Aug 29, 2024 20:53 ET

  • Paradigm Biopharmaceuticals Ltd: Half Yearly Report and Accounts

    Feb 27, 2024 20:15 ET

  • Paradigm Biopharmaceuticals Ltd: 2023 Annual Report and Appendix 4E

    Aug 25, 2023 01:53 ET

    • Read more

    Trending Stocks
    ASX High Dividend ASX High Dividend
    Symbol Div YieldTTM Dividend TTM
    Origin Energy Ltd
    ORG
    4.54% 0.48
    Rio Tinto Ltd
    RIO
    5.26% 6.36
    BHP Group Ltd
    BHP
    5.60% 2.28
    Telstra Group Ltd
    TLS
    4.53% 0.18
    Fortescue Ltd
    FMG
    10.44% 2.02

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Jan 23, 2025

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data